Pennsylvania drug program portrayed as a life-saving tool
An online prescription drug monitoring program in Pennsylvania could help doctors and pharmacists keep painkillers away from addicts, medical professionals said on Monday, as state lawmakers returned to Harrisburg to discuss the topic.
“The database is a vital tool that will help save lives,” said Dr. Michael Ashburn, a medical professor at the University of Pennsylvania and director of the Penn Pain Medicine Center in Philadelphia. “But its presence itself will not solve the problem of prescription drug abuse.”
Health care officials, lawmakers and law enforcement agencies are searching for ways to combat a crisis in drug overdose deaths that tops 36,000 a year.
The state House of Representatives late last year passed legislation to overhaul the state's 41-year-old prescription drug monitoring program. A Senate version is scheduled for discussion next week.
More than 100 people a day die from drug overdoses nationwide, according to the Centers for Disease Control and Prevention. Drugs kill four Pennsylvanians each day, with the Keystone State ranking 14th among states at 15.3 deaths per 100,000 people.
“Drug overdose deaths are the leading cause of preventable deaths in the United States,” Dr. Carrie DeLone, the state's physician general, said during a telephone news conference coordinated by the Pennsylvania Medical Society in Harrisburg.
Drug-related deaths have tripled since 1990, after a 10-fold spike in opioid painkiller prescriptions, DeLone said. Addiction to painkillers often leads to heroin abuse, DeLone said, noting about eight in 10 heroin users abused pain medication prescribed by doctors who vow to do no harm.
“That has become a very difficult tightrope to walk,” DeLone said.
A digital drug-monitoring database would allow medical professionals to see patients' medical histories in real time, including the names of their doctors, medications and pharmacies, the medical professionals said.
Law enforcement agencies would need probable cause to seek information from a drug-monitoring database envisioned in House and Senate bills. The same is true for the current database, which exists only in paper form.
The digital version would establish an expanded database of drug classifications, available instantly to medical professionals. Only the Senate version would require doctors and pharmacists to check it before prescribing or issuing a narcotic for pain to a patient for the first time.
Doctors who participated in Monday's discussion differed on whether checking the database should be required. Dr. John Goldman, an infectious disease specialist from PinnacleHealth in Harrisburg, said it's important because of doctor-shopping and pill-shopping by patients.
“It should be mandatory checking for narcotic medicines, simply because some people seeking them are very good at it,” he said. “Physicians are notoriously bad at figuring out who has chronic pain and who does not.”
Jason Cato is a staff writer for Trib Total Media. He can be reached at 412-320-7936 or firstname.lastname@example.org.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.